SCHEMBL7741435

SCHEMBL7741435

COC(=O)[C@H](O)CCN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1556637 1.00
SCHEMBL1555156 1.00
Hydrochloric Acid SCHEMBL1094574 0.98 GABRR1 (0.38)
Hydrochloric Acid SCHEMBL5317901 0.98 GABRR1 (0.38)
Sulfuric Acid SCHEMBL30931572 0.92 CA14 (0.36)
SCHEMBL7826438 0.86 CA1 (0.39)
SCHEMBL5076556 0.86 CA1 (0.39)
SCHEMBL22525167 0.84 GABRR1 (0.36)
SCHEMBL22820651 0.83
SCHEMBL22805133 0.83

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6420427-B1 PREVENTION AND/OR TREATMENT OF RHEUMATOID DISEASES, ARTHROSTEITIS, UNUSUAL BONE RESORPTION, OSTEOPOROSIS, PERIODONTITIS, INTERSTITIAL NEPHRITIS, ARTERIOSCLEROSIS, PULMONARY EMPHYSEMA, CIRRHOSIS, CORNEA INJURY ONO PHARMACEUTICAL CO., LTD. (JP) 2002-07-16 US disclosed
EP-1024134-A1 AMINOBUTANOIC ACID DERIVATIVES ONO PHARMACEUTICAL CO., LTD. (JP) 2000-08-02 EP disclosed